These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28190773)

  • 1. β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice.
    Rui J; Deng S; Arazi A; Perdigoto AL; Liu Z; Herold KC
    Cell Metab; 2017 Mar; 25(3):727-738. PubMed ID: 28190773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
    Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
    J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes.
    Sherry NA; Kushner JA; Glandt M; Kitamura T; Brillantes AM; Herold KC
    Diabetes; 2006 Dec; 55(12):3238-45. PubMed ID: 17130466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.
    Kryvalap Y; Lo CW; Manuylova E; Baldzizhar R; Jospe N; Czyzyk J
    J Biol Chem; 2016 Jan; 291(1):266-78. PubMed ID: 26578518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
    Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life and death of β cells in Type 1 diabetes: A comprehensive review.
    Wilcox NS; Rui J; Hebrok M; Herold KC
    J Autoimmun; 2016 Jul; 71():51-8. PubMed ID: 27017348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
    Gill RG; Pagni PP; Kupfer T; Wasserfall CH; Deng S; Posgai A; Manenkova Y; Bel Hani A; Straub L; Bernstein P; Atkinson MA; Herold KC; von Herrath M; Staeva T; Ehlers MR; Nepom GT
    Diabetes; 2016 May; 65(5):1310-6. PubMed ID: 26718498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
    Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
    Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell mass and type 1 diabetes: going, going, gone?
    Akirav E; Kushner JA; Herold KC
    Diabetes; 2008 Nov; 57(11):2883-8. PubMed ID: 18971435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetes.
    Dirice E; Kahraman S; De Jesus DF; El Ouaamari A; Basile G; Baker RL; Yigit B; Piehowski PD; Kim MJ; Dwyer AJ; Ng RWS; Schuster C; Vethe H; Martinov T; Ishikawa Y; Teo AKK; Smith RD; Hu J; Haskins K; Serwold T; Qian WJ; Fife BT; Kissler S; Kulkarni RN
    Nat Metab; 2019 May; 1(5):509-518. PubMed ID: 31423480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
    Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
    Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes.
    Perna-Barrull D; Rodriguez-Fernandez S; Pujol-Autonell I; Gieras A; Ampudia-Carrasco RM; Villalba A; Glau L; Tolosa E; Vives-Pi M
    Sci Rep; 2019 Feb; 9(1):1235. PubMed ID: 30718757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
    Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
    J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
    Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
    Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.
    Waldron-Lynch F; von Herrath M; Herold KC
    Novartis Found Symp; 2008; 292():146-55; discussion 155-8, 202-3. PubMed ID: 19203097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
    Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
    Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
    Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
    J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.